Positron Emission Tomography (PET) in Oncology
Since its introduction in the early nineties as a promising functional imaging technique in the management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has become a cornerstone in several oncologic procedures such as tumor staging and restaging, treatment efficacy assessment durin...
Main Authors: | Andrea Gallamini, Colette Zwarthoed, Anna Borra |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/6/4/1821 |
Similar Items
-
Current Role and Future Prospects of Positron Emission Tomography (PET)/Computed Tomography (CT) in the Management of Breast Cancer
by: Nicole Robson, et al.
Published: (2024-02-01) -
Imaging Inflammation with Positron Emission Tomography
by: Janette Iking, et al.
Published: (2021-02-01) -
PET Imaging in Neuro-Oncology: An Update and Overview of a Rapidly Growing Area
by: Antoine Verger, et al.
Published: (2022-02-01) -
Prospective Assessment of Fluorine-18-Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography (FDG-PET/CT) for Early Identification of Checkpoint-Inhibitor-Induced Pseudoprogression
by: Sif Homburg, et al.
Published: (2024-02-01) -
Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment response
by: Salma M. Borg, et al.
Published: (2024-04-01)